Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease
Saved in:
| Main Authors: | Hiroaki Satoh, Sou Hattori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2022-06-01
|
| Series: | Contemporary Oncology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Nivolumab-and-ipilimumab-therapy-in-a-patient-with-non-small-cell-lung-cancer-with-chronic-kidney-disease,3,47466,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study
by: Toshiyuki Sumi, et al.
Published: (2025-01-01) -
Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01) -
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study
by: Yuhei Kurata, et al.
Published: (2025-05-01) -
Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database
by: Xianyu Dai, et al.
Published: (2025-07-01) -
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
by: Satoshi Endo, et al.
Published: (2025-01-01)